| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. | Chief Commercial Officer | Restricted Stock Units | 0 | $706,800 | $5.89 | 24 Feb 2026 | Direct |
| IOVANCE BIOTHERAPEUTICS, INC. | Chief Commercial Officer | Common Stock | 139,381 | $526,860 | $3.78 | 24 Feb 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| IOVA | IOVANCE BIOTHERAPEUTICS, INC. | 24 Feb 2026 | 3 | -$129,144 | 4 | Chief Commercial Officer | 26 Feb 2026, 17:00 |
| IOVA | IOVANCE BIOTHERAPEUTICS, INC. | 10 Feb 2026 | 3 | -$42,770 | 4 | Chief Commercial Officer | 12 Feb 2026, 17:00 |
| IOVA | IOVANCE BIOTHERAPEUTICS, INC. | 05 Jun 2025 | 1 | +$55,200 | 4 | Chief Commercial Officer | 06 Jun 2025, 16:05 |
| IOVA | IOVANCE BIOTHERAPEUTICS, INC. | 10 Feb 2025 | 3 | $0 | 4 | Chief Commercial Officer | 12 Feb 2025, 17:17 |
| IOVA | IOVANCE BIOTHERAPEUTICS, INC. | 10 Feb 2025 | 0 | $0 | 3 | Chief Commercial Officer | 12 Feb 2025, 17:15 |